In various bacterial infection models, such as Mycobacterium tuberculosis, Salmonella, and Listeria monocytogenes, AGK2 chemical inhibitors have been used to inhibit SIRT2 biological activity to explore the role of SIRT2 in bacterial pathogenic mechanisms. This evidence concerns the gene SIRT2 and bacterial infectious disease.